The Scoliosis Research Society (SRS) 47th Annual Meeting is taking place in Chicago right now. K2M, Inc., the device company focused on delivering minimally invasive solutions to complex spinal pathologies and a frequent visitor to our pages, has chosen the event to announce the launch of its Serengeti® Complex Spine Minimally Invasive Retractor System.
K2M says the Serengeti Complex Spine system brings the company’s focus on complex spine and minimally invasive together into one system by providing surgeons with the ability to address deformity, trauma, and tumour, while promoting tissue preservation.
Serengeti Complex Spine features next generation instrumentation to perform complex reduction, controlled manipulation, and above-skin compression and distraction without compromising the option for direct visualisation. The system provides the ability to attach and remove the Minimally Invasive Reduction Tunnels intraoperatively, combining the benefits of a traditional rigid system with the revolutionary benefits of the flexible, polymer Serengeti Retractor.
Serengeti features a screw-based method of retraction, allowing for a fixed position to the anatomy. This simplified design allows for one-step, percutaneous placement of the screw and retractor, providing improved access for rod introduction.
According to Steven M. DeLuca, DO, MS, orthopedic surgeon with the Orthopedic Institute of Pennsylvania, “Spinal surgery, from the simplest to the most complex procedures, is dynamic and can change mid-course. Serengeti Complex Spine allows for on-the-spot decision making, providing surgeons the option to attach or remove the Reduction Tunnels in-situ.”
“This important advancement of our already well received Serengeti Minimally Invasive Retractor System serves as the intersection of our innovation efforts by combining our core competency in deformity with our award-winning minimally invasive technology,” stated Eric Major, K2M’s President and CEO. “Serengeti Complex Spine stands up to the challenge of addressing complex pathologies within a less invasive environment, resulting in more options for surgeons with the ultimate objective of improved outcomes for their patients.”
Source: K2M, Inc.